secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oruka Therapeutics, Inc. (ORKA)
CIK:        0000907654
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0000950170-24-011737
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Two ARCA biopharma directors resign; board reduced from eight to six
--------------------------------------------------------------------

- Raymond L. Woosley and Dan Mitchell resigned from ARCA biopharma board effective Feb 2, 2024.
- Resignations not due to any disagreement with company's operations, policies, or practices.
- Board size reduced from eight to six directors; no new directors appointed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/907654/000095017024011737/0000950170-24-011737-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/907654/000095017024011737/abio-20240202.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-011737

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer